Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future DirectionsLili Mao, Lu Si, Zhonghui Qi et al.|Frontiers in Immunology|2021Cited by 163
Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinomaSiming Li, Jun Guo|BMC Cancer|2014Cited by 54
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinomaSifan Yu, Jun Guo|Cell Death and Disease|2019Cited by 50
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort studyXue Bai, Keith T. Flaherty, Dominika Dulak et al.|EClinicalMedicine|2023Cited by 26
First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumorsDaphne Day, Jun Guo|British Journal of Cancer|2025Cited by 7